Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.48 USD 2.05% Market Closed
Updated: May 18, 2024

Accolade Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Accolade Inc
Total Liabilities & Equity Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
Total Liabilities & Equity
$903.1m
CAGR 3-Years
131%
CAGR 5-Years
81%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Total Liabilities & Equity
$17.4B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Total Liabilities & Equity
$14B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
4%
CVS Health Corp
NYSE:CVS
Total Liabilities & Equity
$249.7B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
13%
Cigna Corp
NYSE:CI
Total Liabilities & Equity
$153.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
11%
Laboratory Corporation of America Holdings
NYSE:LH
Total Liabilities & Equity
$16.5B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
9%

See Also

What is Accolade Inc's Total Liabilities & Equity?
Total Liabilities & Equity
903.1m USD

Based on the financial report for Feb 28, 2023, Accolade Inc's Total Liabilities & Equity amounts to 903.1m USD.

What is Accolade Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
81%

Over the last year, the Total Liabilities & Equity growth was -30%. The average annual Total Liabilities & Equity growth rates for Accolade Inc have been 131% over the past three years , 81% over the past five years .